NOVO.B.DK

305.1

-3.1%↓

GMAB.DK

1,963

0%↓

ZEAL.DK

522.4

-4.91%↓

NOVO.B.DK

305.1

-3.1%↓

GMAB.DK

1,963

0%↓

ZEAL.DK

522.4

-4.91%↓

NOVO.B.DK

305.1

-3.1%↓

GMAB.DK

1,963

0%↓

ZEAL.DK

522.4

-4.91%↓

NOVO.B.DK

305.1

-3.1%↓

GMAB.DK

1,963

0%↓

ZEAL.DK

522.4

-4.91%↓

NOVO.B.DK

305.1

-3.1%↓

GMAB.DK

1,963

0%↓

ZEAL.DK

522.4

-4.91%↓

Начало・Списък с акции・H Lundbeck A-S

H
H Lundbeck A-S

Затворен

43.94 -0.41

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

43.62

Максимум

43.94

Ключови измерители
By Trading Economics
Приходи	135M 1.1B
Продажби	256M 6.3B
P/E Средно за сектора	11.859 106.172
EPS	1.44
Дивидентна доходност	2.09
Марж на печалбата	17.535
Служители	5,700

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	2.09% 2.31%

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-1.5B 43B
Предишно отваряне	44.35
Предишно затваряне	43.94

H Lundbeck A-S Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

21.11.2025 г., 22:42 ч. UTC

Пазарно говорене

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

21.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

21.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

21.11.2025 г., 21:47 ч. UTC

Пазарно говорене

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

21.11.2025 г., 21:43 ч. UTC

Пазарно говорене

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

21.11.2025 г., 20:18 ч. UTC

Пазарно говорене

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

21.11.2025 г., 20:14 ч. UTC

Пазарно говорене

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

21.11.2025 г., 19:48 ч. UTC

Пазарно говорене

Precious Metals Fall for the Week -- Market Talk

21.11.2025 г., 19:44 ч. UTC

Печалби

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

21.11.2025 г., 19:37 ч. UTC

Пазарно говорене

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

21.11.2025 г., 19:27 ч. UTC

Пазарно говорене

Печалби

Global Equities Roundup: Market Talk

21.11.2025 г., 19:27 ч. UTC

Пазарно говорене

Печалби

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

21.11.2025 г., 19:20 ч. UTC

Пазарно говорене

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

21.11.2025 г., 18:44 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

21.11.2025 г., 18:37 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

21.11.2025 г., 18:34 ч. UTC

Пазарно говорене

Печалби

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

21.11.2025 г., 18:28 ч. UTC

Печалби

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21.11.2025 г., 18:03 ч. UTC

Пазарно говорене

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

21.11.2025 г., 17:24 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

21.11.2025 г., 17:24 ч. UTC

Пазарно говорене

Intuit Seen on Path to Increase Growth -- Market Talk

21.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

21.11.2025 г., 17:05 ч. UTC

Пазарно говорене

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

21.11.2025 г., 16:56 ч. UTC

Пазарно говорене

Gold Recovers as Investors Boost Rate-Cut Bets -- Market Talk

21.11.2025 г., 16:47 ч. UTC

Пазарно говорене

European Gas-Price Forecast to Decline Further on Expanding LNG Supply -- Market Talk

21.11.2025 г., 16:35 ч. UTC

Придобивния, сливания и поглъщания

What Stocks Al Gore's Investment Firm Bought and Sold This Quarter -- Barrons.com

21.11.2025 г., 16:09 ч. UTC

Печалби

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21.11.2025 г., 15:59 ч. UTC

Пазарно говорене

Canadian Consumers Tapping the Brakes, Still See Resilient -- Market Talk

21.11.2025 г., 15:59 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

21.11.2025 г., 15:23 ч. UTC

Пазарно говорене

Bank of Canada Not Expected to Be Swayed by Canadian Retail Trade Data -- Market Talk

21.11.2025 г., 15:17 ч. UTC

Пазарно говорене

Canadian Consumer Spending Softening, But Could Be Worse -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

H Lundbeck A-S Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно H Lundbeck A-S

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company's principal products include Abilify Maintena/Abilify Maintena for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat MDD and schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat dementia; Onfi for epilepsy; Sabril for the treatment of refractory complex partial seizures and infantile spasms; Xenazine for chorea; Deanxit for depression; Cipramil for depression and anxiety; and Cisordinol to treat psychosis. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark.